5:00 – 6:00 pm Thursday, October 28

“It’s my Body!”: Engaging Children and Adolescents Through Goals of Care Discussions on End of Life (206)

Childhood and adolescence are a time to navigate autonomy, yet our medical system looks to parents to make “official” decisions until children are 18 years old. The American Academy of Pediatrics recommends children and adolescents with life-limiting illnesses be provided an opportunity to participate in decisions affecting their care in a developmentally appropriate manner.

Read more...
3:30 – 4:30 p, Thursday, October 28

The Impact of a Global Pandemic on Pediatric Hematology Oncology Nurses, Patients, and Families (203)

Since it was first discovered in Wuhan, China, in December 2019, the SARS-CoV-2 virus has reached nearly every country in the world, causing a once-in-a-lifetime pandemic that has placed undue stress on healthcare providers globally.

Read more...
3:30 – 4:30 pm Thursday, October 28

Joint Topic: Error Prevention — Tier Zero: Preventing Harm Before it Happens (201-2)

The care of the pediatric patient with cancer is complex. Patients are at increased risk of harm from falls, central line infections, thrombosis, and pressure injuries resulting from the treatment they receive. The Harm Prevention Program at our organization provides a structure and processes for identifying and reviewing patient harm events.

Read more...
3:30 – 4:30 pm Thursday, October 28

Joint Topic: Error Prevention — Decreasing CLABSI through inter-specialty nurse rounding (201-1)

Central lines are integral in the delivery of chemotherapy and supportive care for pediatric oncology patients. However, central lines are associated with increased morbidity and mortality, especially in immunocompromised children. After a spike in central line–associated bloodstream infections (CLABSIs) in our hospital, our harm prevention department required weekly checks of every central line.

Read more...
Subscribe to this RSS feed